SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA

  1. Sarafidis, P.
  2. Ferro, C.J.
  3. Morales, E.
  4. Ortiz, A.
  5. Malyszko, J.
  6. Hojs, R.
  7. Khazim, K.
  8. Ekart, R.
  9. Valdivielso, J.
  10. Fouque, D.
  11. London, G.M.
  12. Massy, Z.
  13. Ruggenenti, P.
  14. Porrini, E.
  15. Wiecek, A.
  16. Zoccali, C.
  17. Mallamaci, F.
  18. Hornum, M.
Journal:
Nephrology Dialysis Transplantation

ISSN: 1460-2385 0931-0509

Year of publication: 2019

Volume: 34

Issue: 2

Pages: 208-230

Type: Article

DOI: 10.1093/NDT/GFY407 GOOGLE SCHOLAR

Sustainable development goals